Study | Exclusion reasons | Rmk | Reference |
---|---|---|---|
Vajda b (Vigabatrin) (Epilepsy), 2024 | same data already obtained by other studies | EXCLUDED: Partial overlapping with Battino 2024, no details on the period of exposure during pregnancy, and congenital malformations reported in Vajda 2019 (same number of exposed pregnancies). |
Vajda Seizure 2024; 117:198-201 10.1016/j.seizure.2024.03.002 |